If symptoms significantly impact daily functioning beyond the first week at a new dose, consider extending that dose level for an additional four weeks before increasing
Most clients see the best results with a series of treatments spaced appropriately
Retatrutide Phase 3 Trials and Future Price Trajectory Eli Lilly initiated two phase 3 trials in 2023: TRIUMPH-1: Retatrutide versus placebo in adults with obesity, primary completion estimated Q2 2026
The role of toxins in chronic disease is an area of ongoing research, and while some studies suggest a connection, the evidence is not conclusive for all toxins and all diseases
Topical tranexamic acid, arbutin, kojic acid, and azelaic acid can all be helpful when addressing hyperpigmentation, either instead of hydroquinone or in tandem with it
Due to the slow diffusion of the antibiotics through biofilm matrix, the presence of biofilms represents a big eradication challenge compared to planktonic bacteria (Lewis, 2001